Search Medicines & Medical Devices

Curated Report Builder

Select medicine rows from results below to preview a paid report. Quote is based on selected items.

View Plans
Sign in to unlock report generation

Medicine results for "2.5 IU" 12 medicines

Price column visibility: locked (sign in required)

Page 1 of 1

SPEEDA NLT 2.5 IU/SHD INJECTION

Malawi
PMPB/PL357/2 LIQUID RABIES VACCINE FOR HUMAN USE(vero cell)
Details

INDIRAB NLT 2.5 IU/SHD INJECTION

Malawi
PMPB/PL404/1 HUMAN RABIES VACCINE (PURIFIED, INACTIVATED & LYOPHILIZED)
Details

VAXIRAB N

Tanzania
TZ 20 H 0176 Rabies Vaccine 2.5 IU/vial
Details

Antacid

Tanzania
TAN 00,2497 A02A BEL Magnesium Trisilicate 2.5 IU/ml,Magnesium Bicarbonate 2.5 IU/ml,Sodium Bicarbonate 2.5 IU/ml
Details

ABHAYRAB (RABIES BP RAB) FREEZE DRIED 2.5 IU PER VIAL

Ghana
FDA/HVC/243-11021 RABIES VACCINE BP RAB
Details

Abhayrab vaccine

Zambia
088/001 Rabies virus (L. Pasteur 2061/ Vero Strain propagated in Vero Cells), Inactivated ≥2.5 IU
Details

Glanvac 3 Vaccine

Zambia
327/712V Clostridium perfringens Type D ≥ 5 IU/ml,Clostridium tetani ≥ 2.5 IU/ml,Corynebacterium pseudotuberculosis ≥ 6 IU/ml
Details

Prondivax Vaccine

Zambia
471/707V Clostridium haemolyticum 0 IU,Clostridium novyi Strain 2.5 IU,Clostridium perfringens Type C Strain A 10 IU,Clostridium perfringens Type D 2 IU
Details

RABIVAX -S

Tanzania
TZ 18 H 0161 Purified Rabies Antigen (Rabies virus Pitman-Moore Strain 3218-VERO adapted and grown on vero cells, inactivated by using β - propiolactone) 2.5 IU/ml
Details

Coglavax vaccine

Zambia
346/717V Alpha Toxoid Of Clostridium Perfringens Type A 2,0 IU/ml,Alpha Toxoid Of Clostridium Novyi B (Oedematíens) 3.5 IU/ml,Anaculture Of Clostridium Chauvoei 90 %,Beta Toxoid Of Clostridium Perfringens Type C 10.0 IU/ml,Epsilon Toxoid Of Clostridium Perfringens Type D 5.0 IU/ml,Toxoid Of Clostridium Septicum 2.5 IU/ml,Toxoid Of Clostridium Tetani 2.5 IU/ml
Details

ComBe Five

Tanzania
TZ 16 H 0219 Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed). 5 ml,Hepatitis B Surface antigen protein 12.5 IU,Pertusis (Whole cell) 16 Lf/0.5ml,Purified Capsular Hib polysaccharide 11 IU,Tetanus Toxoid 5.5 q.s to 3.0ml
Details

Covexin 10 Vaccine

Zambia
331/713VD C. chauvoei 90 % Units,C. haemolyticum 10 Units,C. novyi type B toxoid 3.5 Units,C. perfringens type A toxoid 0.5 Units,C. perfringens type B toxoid 10 IU,C. perfringens type C toxoid 10 IU,C. perfringens type D toxoid 5 IU,C. septicum toxoid 2.5 IU,C. sordellii toxoid 1 unit,C. tetani toxoid 2.5 IU
Details

Elsewhere on MedStatus

"2.5 IU" also matches these.

Active ingredients

5+

Alpha Toxoid Of Clostridium Perfringens Type A 2,0 IU/ml,Alpha Toxoid Of Clostridium Novyi B (Oedematíens) 3.5 IU/ml,Anaculture Of Clostridium Chauvoei 90 %,Beta Toxoid Of Clostridium Perfringens Type C 10.0 IU/ml,Epsilon Toxoid Of Clostridium Perfringens Type D 5.0 IU/ml,Toxoid Of Clostridium Septicum 2.5 IU/ml,Toxoid Of Clostridium Tetani 2.5 IU/ml

1 product

C. chauvoei 90 % Units,C. haemolyticum 10 Units,C. novyi type B toxoid 3.5 Units,C. perfringens type A toxoid 0.5 Units,C. perfringens type B toxoid 10 IU,C. perfringens type C toxoid 10 IU,C. perfringens type D toxoid 5 IU,C. septicum toxoid 2.5 IU,C. sordellii toxoid 1 unit,C. tetani toxoid 2.5 IU

1 product

Clostridium haemolyticum 0 IU,Clostridium novyi Strain 2.5 IU,Clostridium perfringens Type C Strain A 10 IU,Clostridium perfringens Type D 2 IU

1 product

Clostridium perfringens Type D ≥ 5 IU/ml,Clostridium tetani ≥ 2.5 IU/ml,Corynebacterium pseudotuberculosis ≥ 6 IU/ml

1 product

Diphtheria, Tetanus, Pertussis (Whole Cell), Hepatitis B (rDNA) and Haemophilus influenzae Type b Conjugate Vaccine (Adsorbed). 5 ml,Hepatitis B Surface antigen protein 12.5 IU,Pertusis (Whole cell) 16 Lf/0.5ml,Purified Capsular Hib polysaccharide 11 IU,Tetanus Toxoid 5.5 q.s to 3.0ml

1 product